Oramed Pharm (ORMP) Stock Statistics & Valuation Metrics

Oramed Pharm has a market cap or net worth of $90.69M. The enterprise value is ―.

Oramed Pharm has 40,850,456 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oramed Pharm’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is -7.21%.

The current PE Ratio of Oramed Pharm is 16.86. Oramed Pharm’s PEG ratio is -0.09.

In the last 12 months, Oramed Pharm had revenue of 1.34M and earned 5.53M in profits. Earnings per share was 0.14.

In the last 12 months, operating cash flow was -7.92M and capital expenditures -10.00K, giving a free cash flow of -7.93M billion.

Oramed Pharm pays an annual dividend of ―, resulting in a dividend yield of ―

Oramed Pharm upcoming earnings date is Jul 10, 2024, TBA Not Confirmed.

Oramed Pharm as a current ratio of 3.06, with Debt / Equity ratio of 0.27%

In the past 12 months, Oramed Pharm has paid 0.00 in taxes.

Oramed Pharm EV to EBITDA ratio is -8.71, with an EV/FCF ratio of -12.86.

Oramed Pharm has $142.30M in cash and marketable securities with $429.00K in debt, giving a net cash position of -$141.87M billion.

Gross margin is 0.00%, with operating margin of -1176.79%, and net profit margin of 412.31%.

The average price target for Oramed Pharm is ―, which is 11.43% higher than the current price. The consensus rating is ―